HIGHLIGHTS
- who: Fuxia Xie et al. from the Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the Article: Value of 18F-FDG PET/CT Based on PD-L1 to Predict Outcomes of Immunotherapy in NSCLC, in the Journal: (JOURNAL)
- future: To sum up SUVmax can predict the expression of PD-L1 but whether it can quantify the expression of PD-L1 needs more prospective large-scale research. Basic and clinical studies are needed to prove whether there are other mechanisms by which PD-L1 affects glucose metabolism.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.